Apoptosis
Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
- Caspase(102)
- 14.3.3 Proteins(2)
- Apoptosis Inducers(45)
- Bax(7)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(67)
- MDM2(15)
- p53(128)
- PC-PLC(5)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(151)
- Other Apoptosis(900)
- Apoptosis Detection
- Caspase Substrate
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(32)
Apoptosis 相关产品(2721)
- GC74050PROTAC CDK4/6 degrader 1CAS: 3025082-14-5纯度: >98.00%
PROTAC CDK4/6 degrader 1(化合物7f)是CDK4和CDK6的双重降解剂,DC50分别为10.5和2.5 nM。
- GC74305CD24/Siglec-10 blocking peptide, CSBP纯度: >99.00%
CD24/Siglec-10 blocking peptide, CSBP不仅可以阻断CD24/ siglece -10的相互作用,还可以阻断PD-1/PD-L1的相互作用。
- GC74424BoserolimabCAS: 2444297-08-7纯度: >99.00%
Boserolimab(MK-5890)是一种人源化激动剂单克隆抗体,与CD27结合提供共刺激信号,增强T细胞介导的反应。
- GC74430ExlinkibartCAS: 2642171-64-8纯度: >99.00%
Exlinkibart(LVGN-6051)靶向TNFRSF9,是一种通过互补决定区(CDR)移植技术人源化的IgG1κ抗体。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC74030 | ASCT2-IN-2 | - | >99.00% | |
ASCT2-IN-2(化合物25e)是一种ASCT2抑制剂,IC50为5.14μM。 | ||||
| GC74042 | SpiD3 | 3033533-25-1 | >98.00% | |
SpiD3是一种新型的螺环二聚体。 | ||||
| GC74043 | Bfl-1-IN-2 | - | >99.00% | |
Bfl-1-IN-2(化合物13)是Bfl-1的可逆共价抑制剂(IC50:4.3μM)。 | ||||
| GC74047 | UR778Br | 866127-80-2 | >99.00% | |
UR778Br靶向IQGAP1蛋白的GTP酶激活蛋白相关结构域(GRD结构域)。 | ||||
| GC74050 | PROTAC CDK4/6 degrader 1 | 3025082-14-5 | >98.00% | |
PROTAC CDK4/6 degrader 1(化合物7f)是CDK4和CDK6的双重降解剂,DC50分别为10.5和2.5 nM。 | ||||
| GC74070 | INF 195 | 1211379-56-4 | >99.00% | |
INF 195是一种NLRP3抑制剂。 | ||||
| GC74075 | SC428 | 1898232-70-6 | >98.00% | |
SC428是一种靶向N-末端结构域的雄激素受体(AR)抑制剂。 | ||||
| GC74080 | TASIN-30 | 1678515-93-9 | >98.00% | |
TASIN-30是一种EBP抑制剂,EBP竞争的EC50值为0.097 μM, DHCR7竞争的EC50值为50 μM。 | ||||
| GC74090 | Dimethyl fumarate-d2 | 23057-98-9 | >99.00% | |
Dimethyl fumarate-d2是氘标记的富马酸二甲酯。 | ||||
| GC74102 | Apomine | 126411-13-0 | >99.00% | |
Apomine (SR-45023A)是一种抑制胆固醇合成中甲羟戊酸/类异戊二烯途径的抗肿瘤药物。 | ||||
| GC74159 | MK-0731 | 845256-65-7 | >99.00% | |
MK-0731是一种选择性、非竞争性和变构驱动蛋白纺锤体蛋白(KSP)抑制剂,IC50为2.2 nM,pKa为7.6。 | ||||
| GC74187 | Salicylic acid-13C6 | 1189678-81-6 | >97.00% | |
Salicylic acid-13C6是13c标记的水杨酸。 | ||||
| GC74252 | Euphornin | 80454-47-3 | >98.00% | |
Euphornin是一种抗癌剂,可从E. helioscopia中分离得到。 | ||||
| GC74256 | Condurango glycoside A | 11051-90-4 | >95.00% | |
Condurango glycoside A是p53的激活剂。 | ||||
| GC74267 | Propylparaben-d4 | 1219802-67-1 | >99.00% | |
Propylparaben-d4是氘标记的尼泊金丙酯。 | ||||
| GC74270 | Penduletin | 569-80-2 | >99.00% | |
Penduletin是一种黄酮类化合物,可以从白蜡和牡荆中分离出来。 | ||||
| GC74305 | CD24/Siglec-10 blocking peptide, CSBP | - | >99.00% | |
CD24/Siglec-10 blocking peptide, CSBP不仅可以阻断CD24/ siglece -10的相互作用,还可以阻断PD-1/PD-L1的相互作用。 | ||||
| GC74313 | MYBMIM | - | >99.00% | |
MYBMIM是MYB:CBP/P300复合物分子组装的抑制剂。 | ||||
| GC74358 | PNC-27 acetate | - | >99.00% | |
PNC-27 acetate是一种嵌合p53-穿透素肽,以p53肽样结构与HDM-2结合,诱导选择性膜孔形成并导致癌细胞裂解。 | ||||
| GC74380 | Ac-VRPR-AMC TFA | - | >99.00% | |
Ac-VRPR-AMC TFA是一种荧光的metacaspase底物。 | ||||
| GC74422 | Duvakitug | 2750005-84-4 | >99.00% | |
Duvakitug是一种人源IgG1-λ2单克隆抗体,靶向TNFSF15/TL1A。 | ||||
| GC74424 | Boserolimab | 2444297-08-7 | >99.00% | |
Boserolimab(MK-5890)是一种人源化激动剂单克隆抗体,与CD27结合提供共刺激信号,增强T细胞介导的反应。 | ||||
| GC74430 | Exlinkibart | 2642171-64-8 | >99.00% | |
Exlinkibart(LVGN-6051)靶向TNFRSF9,是一种通过互补决定区(CDR)移植技术人源化的IgG1κ抗体。 | ||||
| GC74441 | Evunzekibart | 2639688-77-8 | >97.00% | |
Evunzekibart (tor -1017)是一种Fc-γ受体条件4-1BB激动剂和igg4型抗体。 | ||||
